中风治未病理论的文献研究及其在临床中的应用探讨
摘要
中风病(stroke)是指在气血内虚的基础上,因劳倦内伤、嗜食厚味及饮酒等诱因,引起脏腑阴阳失调,气血逆乱,直冲犯脑,导致脑脉痹阻或血溢脑外,以突然昏仆,半身不遂,口舌歪斜,语言蹇涩或不语,偏身麻木为主症,起病急、变化快,好发于中老年人,相当于西医的脑血管病或脑卒中。《中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2010》中报告脑血管病已成为我国城市和农村人口的第一位致残和死亡原因,且发病有逐年增多的趋势。现代流行病学研究表明,我国每年有150万到200万新发脑卒,年脑卒中死亡率为58-142/10万人口。因此预防中风病是我国目前面临的重大医疗卫生课题。中医药学有数千年的发展历史,在中风病防治方面有,大量的临床实践,丰富的治疗方法,完善的治未病理论,这些都是我们宝贵的临床财富。那么如何将其整理、归纳、分析、总结,运用到今天中风病的治未病当中去,是当前的一项重要课题。
从《黄帝内经》开始,在中医2000多年的发展历史上,历代中医学家对中风病的防治都倾注了大量的心血,中医药在防治中风病方面一直发挥着重要的作用。但遗憾的是,临床上一直存在对中风病“重治疗而轻预防”的现象。中医虽然有很好的“治未病”理论,但针对中风病治未病的论述基本上都是只言片语,散在于各种文献当中,纷繁散乱。为此,笔者搜集整理了从《内经》到当代在中风病防治方面做出重大贡献的著名医家的著作,对各位医家明确提出的预防中风发作或复发的原文,整理摘录出来,并借助现代的中国知网等数据库,以古今对照的方式,对这些中风病防治思想和治未病的思路进行探析。在此基础上,我们结合当今中风病防治“跟着指南走”的时代特点,探讨了如何在指南的基础上,利用现代计算机软件技术,发挥中医文献的价值,走出一条中西医结合中风治未病之路。
研究目的：
本文旨在发掘中医中风病防治的文献资源,探讨如何在目前医疗环境中更好地发挥中医治未病理论优势,开发中风治未病软件,为患者提供最佳的中风病综合预防方案。
研究方法：
本研究按照文献研究方法中“文献的收集、分析整理以及临床应用”的研究方法开展研究,具体研究方法包括：
1.确定中风病的文献查找范围
我们参考了上海文献研究所出版的《中风病专辑》、《古今名医临证金鉴》等中风病中医文献专著,它们收集了部分先秦到民国的有关中风病的文献论述,但这两本文献专辑在唐代以后所收集的中风病文献并不全面,而且没有对所收集的文献资料进行分析,很多内容与中风病无关,而是一些外感疾病、面神经炎或癫痫等其他内科疾病。鉴于此,本课题在参考两部专辑基础上,通过翻阅《黄帝内经》,《金匮要略》,《中藏经》,《黄帝明堂灸经》、《针灸甲乙经》、《诸病源候论》,《唐宋金元名医全书大成》,《明清名医全书大成》,《中医临床必读丛书》的通用著作、内科、针灸科、养生等方面的书目,《民国名医著作精华》,排除四部丛书中有关外科、妇科、儿科、眼科、骨伤科、耳鼻喉科等与中风病无关的论述,最终确定了《黄帝内经》、张仲景、《中藏经》、巢元方、孙思邈、王焘、刘完素、李东垣、朱丹溪、王执中、罗天益、薛己、张景岳、赵献可、李中梓、龚廷贤、喻嘉言、姜天叙、李用粹、沈金鳌、陈修园、叶天士、王清任、张士骧、张山雷、张锡纯26为医家为古代研究对象,现代文献部分以2009年国家首次评选的30位国医大师、当代中风病中医名家王永炎、石学敏等团队所发表的中风病相关论文、专著、近些年发表的一些国家级重大中风病预防相关课题成果为对象。确定研究对象后,对古代医家的研究,以目前出版的医学全书为文献来源,比如陈修园,以《陈修园医学全书》为本,无医学全书的医家通过网络、图书馆和自己购书,尽量全面地研究其所有著作,现代医家除了研究其中风专著外,结合中国知网等网络资源进行全面搜集整理。
2.建立中风病相关文献纳入及排除标准
纳入标准：本研究按照《中医大辞典》目录及具体词目介绍,制定如下主题词：“中风”、“风痱”、“风懿”、“类中风”、“内风”、“半身不遂”、“瘫”“痪”、“厥”、“偏枯”,在上述确定的研究文献范围内,严格按照本文提出的中风病定义对文献进行初步筛选,纳入符合要求的文献内容。第二步筛选是通过人工阅读,对文献中有关中风病发作之前的预防、延缓中风发作、发病之后预防病情加重、预防复发的理论和方法筛选出来,最终作为研究对象。对于预防和治疗都有涉及的文献只纳入有关预防部分,如果存在预防和治疗难以分开的文献,为了保证该研究的全面性,将其全部纳入为研究对象。
排除标准：与中风病定义不符的内容,与中风病预防无关的内容,只涉及中风病治疗的内容,与前代医家论述重复的内容,以上内容予以排除。
3.综合运用古汉语知识、中医脑病知识、西医神经内科知识及现代信息技术,对目标文献的使用价值进行综合分析。
4.结合时代特点,探讨如何在西医指南治疗基础上利用好古今中医文献有关中风治未病的方法和思路,制定一条规范有效的中西医结合综合预防中风病之路。
5.提出“中风治未病软件系统”的设想,并进行和初步的设计和开发。
研究内容：
1.第1篇的文献资料搜集整理和分析
我们按照上述研究方法,对确定的古今30多个研究对象的中风病防治理论、方法、临床医案等进行了全面归纳总结,将文献中明确提出中风治未病的内容进行了原文摘录,并以古今对照、前后互参的方式进行了分析,总结了前人预防中风病理论和方法的可信性、可行性。
2.第2篇中风治未病方法探讨
第2篇在总结整理前人中风治未病文献的同时,不断反思中风病目前防治的现状。笔者认为,在靶向治疗、操作规范、循证医学证据丰富等方面西医存在优势,而中医“治未病”理论在中风病预防中则具有“更早干预”、“动态干预”、“手段多样”、“价廉效优”、“贴近生活”五方面优势。所以,中西医学各具优势,各有特点,互补性强,在目前的预防中风病方面,中西医结合综合防治中风是主流方向。那么,在西医治疗基础上,如何发挥中医药在中风病治未病中的优势,为患者提供更好的医疗服务,是目前中医药防治中风病面临的重要课题,也是本研究主要思考、探讨的问题。
本研究在总结前人防治中风病的各种文献基础上,提出中风病的治未病应该表述为：无病养生,危险干预,辨治先兆,截断病程,防止复发5各方面。在“中篇”笔者以上述五个方面为纲领,系统探讨了这五个治未病的不同阶段的确切定义,诊断方法,并将中医对中风病因、中风先兆的理论,和现代医学对中风病因、中风风险评估的理论结合起来,提出了Framingham危险评分、高血压分层分级评估、血脂异常危险分层评估、房颤评估四大模型合一,并结合其他危险因素,比如镰状细胞病、动脉炎、下肢静脉栓塞症、脑血管畸形、高凝状态等,比较全面的包含了中风的各种危险因素,形成了一种全新的风险评估方法。对评估结果,本研究沿用目前公认的低危、中危、高危、很高危四个层次分层方法,并将这种风险评估的“五阶段四层次”推广到大多数人群。我们认为预防中风病的最好方式是“恰当的风险评估和针对性的干预措施”。在此基础上,我们又探讨了如何利用“上篇”总结归纳出的文献进行中风病中西医结合防治,发挥中医药中风治未病的优势。其中,西医的内容是根据目前我国发布的最新的国家级指南和部分美国、欧洲、澳大利亚等国外最新相关指南,中医部分采用的标准是：现代研究部分的证据原则上采用国家级课题的成果,古代部分采用标准是根据历代中医文献经过古今对比后广泛被后世认可的部分,部分有争议的内容采用后进行说明。我们的目标是为每位患者提供标准规范而又是目前证据最好的个体化中风治未病方案。
3.第3篇“中风治未病软件系统”的设计
在第3篇,考虑到中风病治未病的患者多数都是在医疗门诊或者在社区,我们为了更好的推广使用本研究提出的“恰当的风险评估和针对性的中西医综合预防方法”,我们提出了“中风治未病软件系统”的设想,希望借助现代计算机软件科技手段,研发一种可以面向社会任何人群进行风险评估并给出个体化预防方案的系统。这个系统是一个综合现代医学各种指南的证据,充分吸收中西医学各自优势,可以用于门诊和基层的中风病风险评估及治未病软件系统。它可以面向社会各个年龄阶段、不同性别和具有不同危险的人群进行中风病的危险评估,并给出个体化的预防建议,为患者提供一站式的中风病或心脑血管病的预防门诊服务。我们在研究过程中,充分考虑了目前门诊医生工作的现状和患者的需求,针对性的设计软件,使其具有操作简单、适用广泛、开放发展、方法全面、个体化治疗和医学教育六大特性,并进一步总结了软件辅助下,医生如何为患者提供中风风险评估和中西结合预防中风的综合性、个体化方案。
研究结果：
1.文献整理价值
本研究是中风病中医文献研究中第一次针对预防中风病而非治疗中风病的一次文献整理,我们对所有最终确立的医家的著作进行了完整的搜集,对筛选出的文献进行了详细的分析,把这些医家明确提出预防中风的理论方法以文献摘录的形式呈现出来,对其中的方剂、针灸、医案进行了整理,(方剂整理见附录：中风治未病方剂索引),这样我们对古今中医在中风病预防方面的文献就一目了然,是本研究的文献整理价值的集中体现。
2.中风治未病方法
本研究在对历代医家防治中风病的理论和方法总结基础上提出：中医治未病的五大优势是：更早干预、动态干预、手段多样、价廉效优、贴近生活；中风病的治未病应该表述为：无病养生,危险干预,辨治先兆,截断病程,防止复发5个阶段,并对这五个阶段进行了定义；提出了Framingham危险评分、高血压分层分级评估、血脂异常危险分层评估房颤评估四大模型合一的风险评估方法,它与五阶段理论相结合,可适合大多数人群的中风病风险评估；按照上述五个阶段和不同风险分层,以中西医结合方式探讨并制定了如何为患者提供标准规范的、综合性、个体化中风预防方案；最后,笔者探讨了中风治未病软件系统的前期规划和设计思路,为下一步开发软件奠定了基础,为更好的实现中风分阶段预防,发挥中医治未病优势做好技术准备。
研究结论：
在国家脑卒中及其相关疾病防治指南指导下,借助于现代计算机软件技术,深入挖掘中医在中风病防治方面2000多年积累下的文献资源,发挥中医在中风病治未病方面的优势,可以更好地预防中风病的发生和复发。
Stroke refers to a disease which is due to the reversed flow of Qi and blood to cause the cerebral thrombosis or hemorrhage, and on the basis of deficiency of Qi and blood, the common pathogenesis are over fatigue and internal injury, over eating greasy food and over drinking; the main clinical symptoms are sudden fainting, hemiplegia, wry eyes and mouth, dysphasia or aphasia, hemianesthesia. It marked by acute onset and quick change and is a common senile disease, the same as acute cerebral accident in modern medicine. According to2010China guideline of the secondary prevention of ischemic stroke and transient ischemic attack, stoke has become to the first reason of disability and death, and the morbidity is increasing rapidly. Some epidemic studies show that there are1500000to2000000new strokes per year, and the yearly mortality is58to142death per one hundred thousand people. The prevention of stoke is one of the major task of national public health. Traditional Chinese medicine(TCM) has2000years development and a large of clinical practice and therapies on stroke and systematical theories on Zhiweibing (preventive treatment of disease), so it is meaningful on how to use these values for the help of stroke prevention today.
TCM doctors have taken profound studies on prevention and treatment of stroke in more than2000years of Chinese medicine history. Unfortunately most doctors have been focusing on treating but not preventing stroke throughout history. Traditional Chinese Medicine has systematical theories on Zhiweibing, but for stroke, they are some words scattering in a large number of ancient or present documents. These words are valuable today for the prevention of stroke, so we make a work on collecting and reorganizing these volumes, and take passages on the prevention of stroke occurrence or recrudescence from them. Further more, we contrast these ideas old and new, under the help of some data centers, such as CNKI, and conmbine the west medicine guideline with TCM methods, and design a software system, which all are in order to find a better way for stroke prevention today.
Objective:
To explore TCM documents on stroke prevention and treatment, and to discuss how to bring Zhiweibing theory into play at present health care system; and finally to develop a software of stroke prevention, which can provide patients a comprehensive prevention scheme on the base of best evidence.
Methods:
1. TCM documents collection and reorganization
It is referred to Zhongfenbing Zhuanji (Stroke album), Guji Mingyi Linzheng Jinjian etc. which makes a good collection of the stroke literature old and new, i n add i t ion with Tang Song Jin Yuan Mingyi Quanshu Dacheng, Ming Qin Mingyi Quanshu Dacheng, the volumes on acupuncture, internal medicine, life cultivation of Zhongyi Linchuang Bidu Congshu, Minguo Mingyi Zhuzuo Jinghua, in which limits we make comparison and contrast, and finally makes out nearly30famous books or doctors who made a large contribution on strokes. They are Huangdi Neijing(Huangdi's canon of internal medicine), Zhang Zongjing, Zhongzangjing, Chao Yuanfang, Sun simiao, Wang Tao, Liu Wansu, Li Dongyuan, Zhu Danxi, Wang Zhizhong, Luo Tianyi, Xue Ji, Zhang Jingyue, Zhao Xianke, Li Zhongzi, Gong Tingxian, Yu Jiayan, Jiang Tianxu, Li Yongcui, Shen Jin'ao, Chen Xiuyuan, Ye Tianshi, Wang Qingren, Zhang Shixiang, Zhang Shanlei, Zhang Xichun, Ren Ji xue, Zhang Xuewen. First, we collect every book of these doctors and read the passages on stroke in, and take out the words on stroke prevention, recognize their ideas from pathogenesis, mechanism, and treatment principle and prevention theory. And then a discussion about these ideas would take by the way of historical comparison and CNKI data which may tell us the acceptance and confirm by the following doctors. For the present doctors'study, we take use of the database of CNKI, Weipu, China biological literature, studied from five points, life cultivation, risk intervention, stokes sign treatment, truncation course and recurrence prevention, especially the studies from state level task or famous doctors, such as Wang Yongyan, Shi Xuemin, etc.
2. The discussion on preventive process
At the same time, we rethink the present situation of stroke prevention. Compared with western medicine, Chinese medicine's Zhiweibing theory has five advantages:earlier intervention, dynamic intervention, more therapies, lower-priced effect and close to daily life. But it has disadvantage either. First, almost all therapies are doctors' personal experiences but not evidenced base medicine and no standard for the application result into no guaranteed effect for every patient. Secondly, though we know Chinese medicine has effect on prevention of stroke, but we do not know how much effect it has, and whether the effect exist or not at the base of western medicine treatment. Thirdly, for the same prescription or the same problem, different doctors may have different opinions and always have conflict results. So we get a conclusion that Chinese and Western medicine have complementary advantages. We should take a combination for stroke prevention. So the question is how to take advantage of TCM Zhiweibing theory at the base of standard treatment by western medicine, which is the main focus of us.
According to the study of TCM documents, we conclude Zhiweibing theory for stroke into five stages:life cultivation, risk intervention, stokes sign treatment, truncation course and recurrence prevention. We explored the five stages'definitions and ways of diagnosis. And further the newly achievement of western medicine, such as Framingham study, high blood pressure layered grading diagnosis and dyslipidemia risk stratification are taken into use of stroke risk assessment, and the result described into four levels:low-risk, intermediate-risk, high-risk and very high-risk. Five stages and four levels are united into one and it could be applied to stroke-risk-assessment for most of people. We believe that the best way to prevent stroke is good risk assessment and personal treatment. Next, Five stages and four levels are taken as an outline, and the special treatments are discussed. Among the treatments, the western medicine part is according to the Chinese guideline such as2010Chinese guideline on prevention and treatment of high blood pressure, some from the guideline of oversea countries such as Guidelines for the primary prevention of stroke:a guideline for healthcare professionals from the American Heart Association, the Chinese medicine part is from the conclusion we collected and reorganized out from the ancient and present TCM documents, among which we choose the widely accepted and used in history or which are the results from Chinese state level research.
The present situation of stroke prevention is not good in china. Most patients get such medical service from clinics or community healthcare center; the revised guideline can not be applied into patients quickly as doctor's low profession or busy work. Some patients may not be given enough time to get such knowledge; some may be treated by specialists who have little relative to stroke or known little about these guidelines. Considering stroke prevention is related to many kind of diseases and too much information, a doctor can not manage all, we propose to make an invention of software, called stroke prevention software system. It is software that can provide every people stroke-risk assessment and personal preventing therapies. The therapies are combinations of both TCM methods and western interventions, both daily life guiding and medical suggestions. It takes as much as advantage from both Chinese and western medicines, and characterized by six aspects, which are easy use, wide indication, open and developing, comprehensive interventions, personal intervention and medical education function. It is used specially for clinical or community patients. So at last, we introduce the process of stroke risk assessment and prevention under the help of this software for clinic patients.
Result and Achievements:
1. Literature results
As far as I know, it is the first TCM documentary reorganization on stroke prevention but not stroke treatment. After the study, we get all of the passages from the famous doctors in Chinese history. Peoples later can easily reach their viewpoints, herbal prescriptions, acupuncture or moxibustion methods and case reports on stroke prevention.
2. A new stroke prevention method
TCM Zhiweibing theory has five advantages of earlier intervention, dynamic intervention, more therapies, lower-priced effect and close to daily life. Stroke prevention should be treated according life cultivation, risk intervention, stokes sign treatment, truncation course and recurrence prevention, five stages and low-risk, intermediate-risk, high-risk and very high-risk, four levels. A new risk assessment way is initiated including Framingham scores, high blood pressure layered grading diagnosis and dyslipidemia risk stratification. Both the risk diagnosis and treatments are according to Chinese guideline and in a integrated medicine framework, which aim to provide patients a personal and best-evidence based treatment. At last, we propose a software to help doctors achieve this new stroke prevention means, and we draw out the blueprint of it.
Conclusion:
Under the help of modern computer software technology, it can make a better result to take good use of2000years TCM documents and Zhiweibing theory at base of national guideline of stroke prevention and prevention of some relative diseases.
从《黄帝内经》开始,在中医2000多年的发展历史上,历代中医学家对中风病的防治都倾注了大量的心血,中医药在防治中风病方面一直发挥着重要的作用。但遗憾的是,临床上一直存在对中风病“重治疗而轻预防”的现象。中医虽然有很好的“治未病”理论,但针对中风病治未病的论述基本上都是只言片语,散在于各种文献当中,纷繁散乱。为此,笔者搜集整理了从《内经》到当代在中风病防治方面做出重大贡献的著名医家的著作,对各位医家明确提出的预防中风发作或复发的原文,整理摘录出来,并借助现代的中国知网等数据库,以古今对照的方式,对这些中风病防治思想和治未病的思路进行探析。在此基础上,我们结合当今中风病防治“跟着指南走”的时代特点,探讨了如何在指南的基础上,利用现代计算机软件技术,发挥中医文献的价值,走出一条中西医结合中风治未病之路。
研究目的：
本文旨在发掘中医中风病防治的文献资源,探讨如何在目前医疗环境中更好地发挥中医治未病理论优势,开发中风治未病软件,为患者提供最佳的中风病综合预防方案。
研究方法：
本研究按照文献研究方法中“文献的收集、分析整理以及临床应用”的研究方法开展研究,具体研究方法包括：
1.确定中风病的文献查找范围
我们参考了上海文献研究所出版的《中风病专辑》、《古今名医临证金鉴》等中风病中医文献专著,它们收集了部分先秦到民国的有关中风病的文献论述,但这两本文献专辑在唐代以后所收集的中风病文献并不全面,而且没有对所收集的文献资料进行分析,很多内容与中风病无关,而是一些外感疾病、面神经炎或癫痫等其他内科疾病。鉴于此,本课题在参考两部专辑基础上,通过翻阅《黄帝内经》,《金匮要略》,《中藏经》,《黄帝明堂灸经》、《针灸甲乙经》、《诸病源候论》,《唐宋金元名医全书大成》,《明清名医全书大成》,《中医临床必读丛书》的通用著作、内科、针灸科、养生等方面的书目,《民国名医著作精华》,排除四部丛书中有关外科、妇科、儿科、眼科、骨伤科、耳鼻喉科等与中风病无关的论述,最终确定了《黄帝内经》、张仲景、《中藏经》、巢元方、孙思邈、王焘、刘完素、李东垣、朱丹溪、王执中、罗天益、薛己、张景岳、赵献可、李中梓、龚廷贤、喻嘉言、姜天叙、李用粹、沈金鳌、陈修园、叶天士、王清任、张士骧、张山雷、张锡纯26为医家为古代研究对象,现代文献部分以2009年国家首次评选的30位国医大师、当代中风病中医名家王永炎、石学敏等团队所发表的中风病相关论文、专著、近些年发表的一些国家级重大中风病预防相关课题成果为对象。确定研究对象后,对古代医家的研究,以目前出版的医学全书为文献来源,比如陈修园,以《陈修园医学全书》为本,无医学全书的医家通过网络、图书馆和自己购书,尽量全面地研究其所有著作,现代医家除了研究其中风专著外,结合中国知网等网络资源进行全面搜集整理。
2.建立中风病相关文献纳入及排除标准
纳入标准：本研究按照《中医大辞典》目录及具体词目介绍,制定如下主题词：“中风”、“风痱”、“风懿”、“类中风”、“内风”、“半身不遂”、“瘫”“痪”、“厥”、“偏枯”,在上述确定的研究文献范围内,严格按照本文提出的中风病定义对文献进行初步筛选,纳入符合要求的文献内容。第二步筛选是通过人工阅读,对文献中有关中风病发作之前的预防、延缓中风发作、发病之后预防病情加重、预防复发的理论和方法筛选出来,最终作为研究对象。对于预防和治疗都有涉及的文献只纳入有关预防部分,如果存在预防和治疗难以分开的文献,为了保证该研究的全面性,将其全部纳入为研究对象。
排除标准：与中风病定义不符的内容,与中风病预防无关的内容,只涉及中风病治疗的内容,与前代医家论述重复的内容,以上内容予以排除。
3.综合运用古汉语知识、中医脑病知识、西医神经内科知识及现代信息技术,对目标文献的使用价值进行综合分析。
4.结合时代特点,探讨如何在西医指南治疗基础上利用好古今中医文献有关中风治未病的方法和思路,制定一条规范有效的中西医结合综合预防中风病之路。
5.提出“中风治未病软件系统”的设想,并进行和初步的设计和开发。
研究内容：
1.第1篇的文献资料搜集整理和分析
我们按照上述研究方法,对确定的古今30多个研究对象的中风病防治理论、方法、临床医案等进行了全面归纳总结,将文献中明确提出中风治未病的内容进行了原文摘录,并以古今对照、前后互参的方式进行了分析,总结了前人预防中风病理论和方法的可信性、可行性。
2.第2篇中风治未病方法探讨
第2篇在总结整理前人中风治未病文献的同时,不断反思中风病目前防治的现状。笔者认为,在靶向治疗、操作规范、循证医学证据丰富等方面西医存在优势,而中医“治未病”理论在中风病预防中则具有“更早干预”、“动态干预”、“手段多样”、“价廉效优”、“贴近生活”五方面优势。所以,中西医学各具优势,各有特点,互补性强,在目前的预防中风病方面,中西医结合综合防治中风是主流方向。那么,在西医治疗基础上,如何发挥中医药在中风病治未病中的优势,为患者提供更好的医疗服务,是目前中医药防治中风病面临的重要课题,也是本研究主要思考、探讨的问题。
本研究在总结前人防治中风病的各种文献基础上,提出中风病的治未病应该表述为：无病养生,危险干预,辨治先兆,截断病程,防止复发5各方面。在“中篇”笔者以上述五个方面为纲领,系统探讨了这五个治未病的不同阶段的确切定义,诊断方法,并将中医对中风病因、中风先兆的理论,和现代医学对中风病因、中风风险评估的理论结合起来,提出了Framingham危险评分、高血压分层分级评估、血脂异常危险分层评估、房颤评估四大模型合一,并结合其他危险因素,比如镰状细胞病、动脉炎、下肢静脉栓塞症、脑血管畸形、高凝状态等,比较全面的包含了中风的各种危险因素,形成了一种全新的风险评估方法。对评估结果,本研究沿用目前公认的低危、中危、高危、很高危四个层次分层方法,并将这种风险评估的“五阶段四层次”推广到大多数人群。我们认为预防中风病的最好方式是“恰当的风险评估和针对性的干预措施”。在此基础上,我们又探讨了如何利用“上篇”总结归纳出的文献进行中风病中西医结合防治,发挥中医药中风治未病的优势。其中,西医的内容是根据目前我国发布的最新的国家级指南和部分美国、欧洲、澳大利亚等国外最新相关指南,中医部分采用的标准是：现代研究部分的证据原则上采用国家级课题的成果,古代部分采用标准是根据历代中医文献经过古今对比后广泛被后世认可的部分,部分有争议的内容采用后进行说明。我们的目标是为每位患者提供标准规范而又是目前证据最好的个体化中风治未病方案。
3.第3篇“中风治未病软件系统”的设计
在第3篇,考虑到中风病治未病的患者多数都是在医疗门诊或者在社区,我们为了更好的推广使用本研究提出的“恰当的风险评估和针对性的中西医综合预防方法”,我们提出了“中风治未病软件系统”的设想,希望借助现代计算机软件科技手段,研发一种可以面向社会任何人群进行风险评估并给出个体化预防方案的系统。这个系统是一个综合现代医学各种指南的证据,充分吸收中西医学各自优势,可以用于门诊和基层的中风病风险评估及治未病软件系统。它可以面向社会各个年龄阶段、不同性别和具有不同危险的人群进行中风病的危险评估,并给出个体化的预防建议,为患者提供一站式的中风病或心脑血管病的预防门诊服务。我们在研究过程中,充分考虑了目前门诊医生工作的现状和患者的需求,针对性的设计软件,使其具有操作简单、适用广泛、开放发展、方法全面、个体化治疗和医学教育六大特性,并进一步总结了软件辅助下,医生如何为患者提供中风风险评估和中西结合预防中风的综合性、个体化方案。
研究结果：
1.文献整理价值
本研究是中风病中医文献研究中第一次针对预防中风病而非治疗中风病的一次文献整理,我们对所有最终确立的医家的著作进行了完整的搜集,对筛选出的文献进行了详细的分析,把这些医家明确提出预防中风的理论方法以文献摘录的形式呈现出来,对其中的方剂、针灸、医案进行了整理,(方剂整理见附录：中风治未病方剂索引),这样我们对古今中医在中风病预防方面的文献就一目了然,是本研究的文献整理价值的集中体现。
2.中风治未病方法
本研究在对历代医家防治中风病的理论和方法总结基础上提出：中医治未病的五大优势是：更早干预、动态干预、手段多样、价廉效优、贴近生活；中风病的治未病应该表述为：无病养生,危险干预,辨治先兆,截断病程,防止复发5个阶段,并对这五个阶段进行了定义；提出了Framingham危险评分、高血压分层分级评估、血脂异常危险分层评估房颤评估四大模型合一的风险评估方法,它与五阶段理论相结合,可适合大多数人群的中风病风险评估；按照上述五个阶段和不同风险分层,以中西医结合方式探讨并制定了如何为患者提供标准规范的、综合性、个体化中风预防方案；最后,笔者探讨了中风治未病软件系统的前期规划和设计思路,为下一步开发软件奠定了基础,为更好的实现中风分阶段预防,发挥中医治未病优势做好技术准备。
研究结论：
在国家脑卒中及其相关疾病防治指南指导下,借助于现代计算机软件技术,深入挖掘中医在中风病防治方面2000多年积累下的文献资源,发挥中医在中风病治未病方面的优势,可以更好地预防中风病的发生和复发。
Stroke refers to a disease which is due to the reversed flow of Qi and blood to cause the cerebral thrombosis or hemorrhage, and on the basis of deficiency of Qi and blood, the common pathogenesis are over fatigue and internal injury, over eating greasy food and over drinking; the main clinical symptoms are sudden fainting, hemiplegia, wry eyes and mouth, dysphasia or aphasia, hemianesthesia. It marked by acute onset and quick change and is a common senile disease, the same as acute cerebral accident in modern medicine. According to2010China guideline of the secondary prevention of ischemic stroke and transient ischemic attack, stoke has become to the first reason of disability and death, and the morbidity is increasing rapidly. Some epidemic studies show that there are1500000to2000000new strokes per year, and the yearly mortality is58to142death per one hundred thousand people. The prevention of stoke is one of the major task of national public health. Traditional Chinese medicine(TCM) has2000years development and a large of clinical practice and therapies on stroke and systematical theories on Zhiweibing (preventive treatment of disease), so it is meaningful on how to use these values for the help of stroke prevention today.
TCM doctors have taken profound studies on prevention and treatment of stroke in more than2000years of Chinese medicine history. Unfortunately most doctors have been focusing on treating but not preventing stroke throughout history. Traditional Chinese Medicine has systematical theories on Zhiweibing, but for stroke, they are some words scattering in a large number of ancient or present documents. These words are valuable today for the prevention of stroke, so we make a work on collecting and reorganizing these volumes, and take passages on the prevention of stroke occurrence or recrudescence from them. Further more, we contrast these ideas old and new, under the help of some data centers, such as CNKI, and conmbine the west medicine guideline with TCM methods, and design a software system, which all are in order to find a better way for stroke prevention today.
Objective:
To explore TCM documents on stroke prevention and treatment, and to discuss how to bring Zhiweibing theory into play at present health care system; and finally to develop a software of stroke prevention, which can provide patients a comprehensive prevention scheme on the base of best evidence.
Methods:
1. TCM documents collection and reorganization
It is referred to Zhongfenbing Zhuanji (Stroke album), Guji Mingyi Linzheng Jinjian etc. which makes a good collection of the stroke literature old and new, i n add i t ion with Tang Song Jin Yuan Mingyi Quanshu Dacheng, Ming Qin Mingyi Quanshu Dacheng, the volumes on acupuncture, internal medicine, life cultivation of Zhongyi Linchuang Bidu Congshu, Minguo Mingyi Zhuzuo Jinghua, in which limits we make comparison and contrast, and finally makes out nearly30famous books or doctors who made a large contribution on strokes. They are Huangdi Neijing(Huangdi's canon of internal medicine), Zhang Zongjing, Zhongzangjing, Chao Yuanfang, Sun simiao, Wang Tao, Liu Wansu, Li Dongyuan, Zhu Danxi, Wang Zhizhong, Luo Tianyi, Xue Ji, Zhang Jingyue, Zhao Xianke, Li Zhongzi, Gong Tingxian, Yu Jiayan, Jiang Tianxu, Li Yongcui, Shen Jin'ao, Chen Xiuyuan, Ye Tianshi, Wang Qingren, Zhang Shixiang, Zhang Shanlei, Zhang Xichun, Ren Ji xue, Zhang Xuewen. First, we collect every book of these doctors and read the passages on stroke in, and take out the words on stroke prevention, recognize their ideas from pathogenesis, mechanism, and treatment principle and prevention theory. And then a discussion about these ideas would take by the way of historical comparison and CNKI data which may tell us the acceptance and confirm by the following doctors. For the present doctors'study, we take use of the database of CNKI, Weipu, China biological literature, studied from five points, life cultivation, risk intervention, stokes sign treatment, truncation course and recurrence prevention, especially the studies from state level task or famous doctors, such as Wang Yongyan, Shi Xuemin, etc.
2. The discussion on preventive process
At the same time, we rethink the present situation of stroke prevention. Compared with western medicine, Chinese medicine's Zhiweibing theory has five advantages:earlier intervention, dynamic intervention, more therapies, lower-priced effect and close to daily life. But it has disadvantage either. First, almost all therapies are doctors' personal experiences but not evidenced base medicine and no standard for the application result into no guaranteed effect for every patient. Secondly, though we know Chinese medicine has effect on prevention of stroke, but we do not know how much effect it has, and whether the effect exist or not at the base of western medicine treatment. Thirdly, for the same prescription or the same problem, different doctors may have different opinions and always have conflict results. So we get a conclusion that Chinese and Western medicine have complementary advantages. We should take a combination for stroke prevention. So the question is how to take advantage of TCM Zhiweibing theory at the base of standard treatment by western medicine, which is the main focus of us.
According to the study of TCM documents, we conclude Zhiweibing theory for stroke into five stages:life cultivation, risk intervention, stokes sign treatment, truncation course and recurrence prevention. We explored the five stages'definitions and ways of diagnosis. And further the newly achievement of western medicine, such as Framingham study, high blood pressure layered grading diagnosis and dyslipidemia risk stratification are taken into use of stroke risk assessment, and the result described into four levels:low-risk, intermediate-risk, high-risk and very high-risk. Five stages and four levels are united into one and it could be applied to stroke-risk-assessment for most of people. We believe that the best way to prevent stroke is good risk assessment and personal treatment. Next, Five stages and four levels are taken as an outline, and the special treatments are discussed. Among the treatments, the western medicine part is according to the Chinese guideline such as2010Chinese guideline on prevention and treatment of high blood pressure, some from the guideline of oversea countries such as Guidelines for the primary prevention of stroke:a guideline for healthcare professionals from the American Heart Association, the Chinese medicine part is from the conclusion we collected and reorganized out from the ancient and present TCM documents, among which we choose the widely accepted and used in history or which are the results from Chinese state level research.
The present situation of stroke prevention is not good in china. Most patients get such medical service from clinics or community healthcare center; the revised guideline can not be applied into patients quickly as doctor's low profession or busy work. Some patients may not be given enough time to get such knowledge; some may be treated by specialists who have little relative to stroke or known little about these guidelines. Considering stroke prevention is related to many kind of diseases and too much information, a doctor can not manage all, we propose to make an invention of software, called stroke prevention software system. It is software that can provide every people stroke-risk assessment and personal preventing therapies. The therapies are combinations of both TCM methods and western interventions, both daily life guiding and medical suggestions. It takes as much as advantage from both Chinese and western medicines, and characterized by six aspects, which are easy use, wide indication, open and developing, comprehensive interventions, personal intervention and medical education function. It is used specially for clinical or community patients. So at last, we introduce the process of stroke risk assessment and prevention under the help of this software for clinic patients.
Result and Achievements:
1. Literature results
As far as I know, it is the first TCM documentary reorganization on stroke prevention but not stroke treatment. After the study, we get all of the passages from the famous doctors in Chinese history. Peoples later can easily reach their viewpoints, herbal prescriptions, acupuncture or moxibustion methods and case reports on stroke prevention.
2. A new stroke prevention method
TCM Zhiweibing theory has five advantages of earlier intervention, dynamic intervention, more therapies, lower-priced effect and close to daily life. Stroke prevention should be treated according life cultivation, risk intervention, stokes sign treatment, truncation course and recurrence prevention, five stages and low-risk, intermediate-risk, high-risk and very high-risk, four levels. A new risk assessment way is initiated including Framingham scores, high blood pressure layered grading diagnosis and dyslipidemia risk stratification. Both the risk diagnosis and treatments are according to Chinese guideline and in a integrated medicine framework, which aim to provide patients a personal and best-evidence based treatment. At last, we propose a software to help doctors achieve this new stroke prevention means, and we draw out the blueprint of it.
Conclusion:
Under the help of modern computer software technology, it can make a better result to take good use of2000years TCM documents and Zhiweibing theory at base of national guideline of stroke prevention and prevention of some relative diseases.
引文
[1]聂惠民,张吉.内经病证辨析[M].沈阳：辽宁科学技术出版社,1988,第1版：228.
[2]王洪图.《黄帝内经》研究大成[M].北京：北京出版社,1997,第1版：1643.
[3](唐)王冰.黄帝内经[M].北京：中医古籍出版社,2003,第1版：1-316.
[4]张锡纯.医学衷中参西录[M].太原：山西科学技术出版社,2009,第1版：320-325.
[5]上海市中医文献研究馆.中风专辑[M].上海：上海科学技术出版社,2001,第1版：81.
[6]王左原.《内经》“治未病”思想的核心—先机扶正[J].中国中医基础医学杂志,2008；14(4)：255-256.
[7]张仲景.中医经典临床必读丛书·匮要略方论[M].北京：中国中医药出版社,2006.10,第1版：19-20
[8]田德禄.中医内科学[M].北京：人民卫生出版社,2002,第1版：272.
[9]陈熠.明清名医全书大成·喻嘉言医学全书[M].北京：中国中医药出版社,1999,第1版：243-244.
[10]叶天士中医临床必读丛书·临证指南医案[M].北京：人民卫生出版社,2006,第1版：19
[11]李敬孝,张岩.侯氏黑散对ICVD兔血流变及脂质过氧化物影响的实验研究[J].四川中医,2007：25(1)：20.
[12]张秋霞,赵晖.侯氏黑散对大鼠大脑中动脉闭塞模型缺血脑组织Na+K+ATP酶及一氧化氮合酶活性的影响[J].首中国实验方剂学杂志,2008；14(7)：31
[13]谭春雨.中医经典临床必读丛书·中藏经[M].北京：人民卫生出版社,2007,第1版：38-45.
[14]丁光迪,倪和宪,王旭东等.诸病源侯论校注[M].北京：人民卫生出版社,1991,第1版：1-55.
[15]张印生,韩学杰.孙思邈医学全书[M].北京：中国中医药出版社,2009,第1版：83-479.
[16]严天放.孙思邈的养生之道[J].养生月刊,2010；1(1)：006
[17]富作平,裴景春.古代中风病针灸处方配穴原则及规律的探讨[J].辽宁中医杂志,2002；29(6)：320
[18]周敬佐.灸治中风60例.辽宁中医杂志,1994；21(11)：521.
[19](唐)王焘.外台秘要[M].北京：人民卫生出版社,1955,第1版：397-398.
[20]姜琳祛风通络说桑枝[J].东方药膳,2009;(03)：38
[21]国家医药管理局中草药中心情报站.药物有效成分手册[M].北京：人民卫生出版社,1986,第1版：123-130.
[22]刘完素.金元四大家医学全书—上册(刘完素医学文集)[M].天津：天津科学技术出版社,1996,第1版：11-164.
[23]丁元庆.论刘完素对中风病的贡献[J].中医文献杂志,1998；16(3)：5-6.
[24]朱震亨.金元四大家医学全书—下册(朱震亨医学文集)[M].天津：天津科学技术出版社,1996,第1版：1685.
[25]盛维忠《薛立斋医学全书·内科摘要》[M].北京：中国中医药出版社,1999,第1版：5.
[26]许沛虎涂晋文.愈风汤对大鼠脑缺血再灌流损伤的保护作用[J].中国中医急症,1997;6(4)：176.
[27]许沛虎涂晋文.愈风汤对大鼠实验性高脂血症血脂及血液流变性的影响[J].湖北中医杂志,1996; (5)：53.
[28]许沛虎涂晋文.愈风汤对大鼠短暂脑缺血再灌注后迟发性神经元死亡加重的保护作用[J].中国实验方剂学杂志,2001;7(5)：30.
[29]李东垣.金元四大家医学全书—上册(李杲医学文集)[M].天津：天津科学技术出版社,1996,第1版：756.
[30]谭春雨.中医经典临床必读丛书·中藏经[M].北京：人民卫生出版社,2007,第1版：63.
[31]朱震亨.金元四大家医学全书—下册(朱震亨医学文集)[M].天津：天津科学技术出版社,1996,第1版：983.1059-1060,1125-1129,1256-1257,1343-1344,1422-1428,1685-1686.
[32]王执中著,黄龙强,黄幼民整理.《针灸资生经／针经摘英集》[M].北京：人民卫生出版社,2007,第1版：182-189.
[33](元)罗天益.卫生宝鉴[M].北京：人民卫生出版社,1983,第1版：4,3,56-75,87.
[34]王和融.薛己论中风病因探要[J].中国中医急症,2003；12(4)：355.
[35]盛维忠.明清名医全书大成·薛己医学全书[M].中国中医药出版社.1999,第1版：5,20.
[36]李志庸.明清名医全书大成·张景岳医学全书[M].北京：中国中医药出版社,1999,第1版：984-1001.
[37]李志庸.明清名医全书大成·张景岳医学全书[M].北京：中国中医药出版社,1999,第1版：899.
[38]赵献可.中医临床必读丛书·医贯[M].北京：人民卫生出版社,2005,第1版：21-31.
[39]包来发.李中梓医学全书[M].北京：中国中医药出版社,1999,第1版：181-190.
[40]包来发.李中梓医学全书[M].北京：中国中医药出版社,1999,第1版：655-656.
[41]李世华,王育学.龚廷贤医学全书[M].北京：中国中医药出版社,1999,第1版：3-5,253-786.
[42]唐东一.搜风顺气丸治疗代谢综合征120例[J].山东中医杂志,2007;26(3)：163.
[43]苏建春.补中益气汤洽验举隅[J].新疆中医药,1995；(1)：49.
[44]李世华,王育学.龚廷贤医学全书[M].北京：中国中医药出版社,1999,第1版：607.
[45]陈熠.喻嘉言医学全书·医门法律[M].北京：中国中医药出版社,1999.8：238
[46]清·喻嘉言.中医经典文库·寓意草[M].北京：中国中医药出版社,2008.12：98
[47]陈熠.喻嘉言医学全书·医门法律[M].北京：中国中医药出版社,1999.8：246-255.
[48]清·姜天叙.风劳朦隔四大证治[M].江苏人民出版社,1957：6-7.
[49]李用粹.中医临床必读丛书·证治汇补[M].北京：人民卫生出版社,2006.6：1.
[50]S Ebrahim, M May, Y Ben Shlomo, P McCarron. J Epidemiol Community Health [J] 2002, 56:102.
[51]田思胜.明清名医全书大成·沈金鳌医学全书[M].北京：中国中医药出版社,1999：221-234.
[52]林惠光,俞宜年.陈修园医学全书·医学实在易[M].北京：中国中医药出版社,1999.8：561-562
[53]孙中堂.尤在泾医学全书·金匮翼[M].北京：中国中医药出版社,1999.8：189-193
[54]林惠光,俞宜年.陈修园医学全书·时方妙用[M].北京：中国中医药出版社,1999.8：881-882.
[55]清·叶天士.临证指南医案[M].上海：人民卫生出版社,2006.6：19.
[56]明国臣.叶天士医学全书[M].北京：中国中医药出版社,1999.1041.
[57]谢文英,常学辉.中国中医基础医学杂志[J].2007,13(5)：330.
[58]清·叶天士.临证指南医案[M].上海：人民卫生出版社,2006.6：6-10.
[59]清·王清任.医林改错[M].太原：陕西科学技术出版社,2010.7：84-102.
[60]Liao CL, Tong L, Chen YY. Effect of Buyanghuanwu decoction on neuronal nitric-oxide synthase ex-pression after permanent focal cerebral ischemia in rats. Di Yi Jun Yi Da Xue Xue Bao,2004,24 (8):864-868
[61]Qu HD, Tong L, Shen J G, etal. Protective effect of Buyanghuanwu Tang on cultured rat cortical neurons against hypoxia induced apoptosis. Di Yi Jun Yi Da Xue Xue Bao,2002, 22 (1):35-38
[62]Zhang J, Li C, Guo X, et al. Effect of buyang huanwu decoction on platelet activating factor content in arterial blood pre-and post-arterial thrombosis in rats. Journal of Traditional Chinese Medicine,2001,21 (4):299-302.
[63]Liu FY, Wen ZB, Zhou CS, et al. "Buyang huanwutang" inhibited the pathogenic process of atherosclerosis induced by cholesterol-rich diet in rabbits. Hu Nan Yi Ke Da Xue Xue Bao,2000,25(1):33-35.
[64]张习东.补阳还五汤防治进展型中风病36例[J].云南中医中药杂志,2009,30(8)：27.
[65]吴云虎,黄龙坚,王殿华.气虚血瘀型再狭窄预防作用研究[J].新中医,2011.5,43(5)：19.
[66]方东海,李明淑,付杰等.补阳还五汤预防脑梗塞复发率及其生存率的对照观察[J].中医药学刊,2004.6,22(6)：1107.
[67]王华.补阳逐五汤治疗气虚血瘫型中风先兆26例[J].中国中医急症,1999.12,8(6)：280.
[68]闫润红 王世民 闫志芳不同黄芪剂量的补阳还五汤对“气虚血瘀”家兔血粘度的影响[J].中药药理与临床,1999,15(1)：7.
[69]张运克.补阳还五汤及拆方抗脑缺血.及再灌注损伤作用机理的临床与实验研究[D].黑龙江中医药大学2002.5：2.
[70]张十骧著,裘庆元辑.历代图书珍本集成-国医百家-类中秘旨[M].工医药学报 社,1917：1-12.
[71]张士骧著,裘庆元辑.历代图书珍本集成-国医百家-雪雅堂医案[M].医学全在线：395,397,403.
[72]于诗俊,叶德铭,盛增秀等.张山雷医集下[M].北京：人民卫生出版社,1995：61.
[73]于诗俊,叶德铭,盛增秀等.张山雷医集下[M].北京：人民卫生出版社,1995：90.
[74]张锡纯.医学衷中参西录[M].太原：山西科学技术出版社,2009.1：155-158,164-167,320-325,351-356,476-481.
[75]蔡业峰.缺血性中风诊断与治疗[M].北京：人民军医出版社,2012.1：204.
[76]任继学.任继学经验集[M].北京：人民卫生出版社,2000：97-112.
[77]任继学.任继学经验集[M].北京：人民卫生出版社,2000：127-138.
[78]张学文,李军等.近代中医名家论治中风病荟萃[M].西安：陕西科学技术出版社,1997.8：190-193.
[79]王景洪,李军,张宏伟.张学文医学求索集[M]..西安：陕西科学技术出版社,1996.01：284-288.
[80]任继学.任继学经验集[M].北京：人民卫生出版社,2000：115.
[81]上海市中风预报协作组.缺血性中风先兆预报和预防性治疗的初步探讨[J].中华医学杂志,1979：12：1-3.
[82]金智敏.珍菊降压片与其他一线降压药治疗原发性高血压临床研究[J].中成药,2001,23(12)：882-884.
[83]申鹏飞.针刺治疗亚急性原发性高血.压病30例.中医杂志,2010,51(1)：57-58.
[84]申鹏飞,石学敏.针刺治疗原发性高血.压病的临床疗效观察.辽宁中医杂志,2010,37(9)：1802-1803.
[85]王宁,张昆,郑君.隔芪香散灸脐法治疗高血压肝阳上亢证30例[J].四川中医,2007,25(4)：6.
[86]吴晓青,杨婷.高血压病的中医研究进展.北京中医药大学学报(中医临床版)[J]2010.07,17(4)：39.
[87]仝小林.糖尿病中医防治指南解读[M].中国中医药出版社,2009.08：14-15.
[88]冯新玲,张定华.糖尿病前期中医证治研究进展[J].实用中医药杂志2011.10,27(10)：736.
[89]仝小林,赵昱,陈良.胰岛B细胞功能保护的中医认识与对策[J].中医杂志,2006,47(12)888-890.
[90]周水平,罗若兰.疏肝健脾法对葡萄糖耐量减低干预作用的临床研究[J].中西医结合研究,2010,6(2)：284-287.
[91]仝小林.糖尿病中医防治指南解读—中医治疗糖尿病的研究进展[M].中国中医药出版社,2009.08：271
[92]谷浩荣,贾春华.糖尿病中医病机及治法研究进展[J].上海中医药杂志,2011,45(1)：84.
[93]陈婷,吴伟,李荣等.血脂异常中医病因病机及治法研究进展[J].北京中医药大学学报(中医临床版),2008.01,15(1)：39-40.
[94]潘涛,施广飞.血脂异常的中医研究进展[J].中西医结合心脑血.管病杂志,2008,6(1)：51-52.
[95]徐玉华,朱雅萍.中医治未病思想防治高脂血症研究进展[J]. 陕西中医2011,32(4)：500-501.
[96]赵水平.血脂异常临床防治2011-2012[M].中华医学电子音像出版社,2011.06：144-145.
[97]吴圣贤,方素钦,林炳辉.脑动脉硬化症的计量诊断研究[J].北京中医药大学学报,2006,29(8)：569.
[98]吴圣贤,林炳辉,方素钦.脑动脉硬化症中医计量诊断前瞻性研究[J].中医杂志,2006,47(7)：535.
[99]Zhang HX, Liu JG, Shi DZ. Effects o f Qixue Bingzhi prescription on hypersensitive C-reactive protein and other indexes in the patient o f cervical atherosclerosis. J Tradit Chin Med(中医杂志),2004,45(12)：907-910.
[100]Dong GJ, Liu JG, Shi DZ, Wang YY, Luan LJ, Cheng YY. Experimental study of water extractives of regulating Qi and Xue prescription on early AS of apo-lipoprotein E deficient mice. J Chin Integrat Med(中西医结合学报),2007,1(5)：45-49.
[101]Ji B, Liu JG, Shi DZ, Wang YY. Effects of different combinations of the active fractions of Qixuebingzhi Formula on VSM C proliferation induced by vascular endothelial cell injury-conditioned medium. J Beijing Univ Tradit Chin Med(北京中医药大学学报),2005,28(1)：30-32.
[102]董国菊,刘剑刚,史大卓.气血并治方胶囊治疗颈动脉粥样硬化的临床研究[J].世界中西医结合杂志,2008,3(1)：29.
[103]田德禄中医内科学[M].北京：人民卫生出版社,2002：271.
[104]王忠,张伯礼,申春娣,等.中风病中医危险因素研究[J].北京中医药大学学报,2002,25(5)：47：52.
[105]许越.中医体质学说在中风病一级预防中的理论研究[D].广州,广州中医药大学,2008：77-78.
[106]王琦.中医体质学[M].北京：人民卫生出版社,2005,第一版：79-82.
[107]王泓午,王玉来,王振海等.缺血性中风发病前24小时内先兆期症状的病例对照研究[J].北京中医药大学学报,1998,21(4)：2.
[108]王泓午,王玉来,金章安等.缺血性中风发病前24-72小时内症状的条件logistic回归分析[J].中国中医急症,2002,11(5)：370.
[109]王泓午,王玉来,金章安等.缺血性中风发病前3-7天内症状的条件logistic回归分析[J].中国中医急症,2003,12(1)：40.
[110]王泓午,王玉来,金章安等.缺血性中风发病前7-30 d内症状的病例对照研究[J].天津中医药,2004,11(6)：470.
[111]张鹤年.缺血性中风的先兆检测与防治[J].上海中医药杂志,1990,5：26.
[112]陈宝生.葛根素治疗中风先兆证临床观察[J].中国中医急症,2004,13(9)：563-564.
[113]杨保林.清开灵治疗中风先兆证56例[J].中国中医急症,1998,7(1)：20.
[114]王舒,石学敏,张存生.“醒脑开窍”针刺法治疗中风先兆的血液流变学观察[J].针灸临床杂志,1995,11(6)：25-28.
[115]徐桂琴,谢雁鸣,邹忆怀等.缺血性中风避免复发中医研究现状[J].辽宁中医杂志,2009,36(5)：858.
[116]邓小兰,赵红,黄燕等.中风病二级预防的研究进展[J].陕西中医,2009,30(9)：1268.
[117]黄燕,陈绍宏.中药灯盏生脉胶囊干预缺血性中风二级预防的多中心、随机对照、双盲临床试验[J].解放军医学杂志,2011.11,36珠江国际卒中论坛会议增刊：3.
[118]常富业,郭玉荣,李辉等.中医学关于卒中二级预防的研究状况与述评[J].辽宁中医杂志,2007,34(5)：567.
[119]陈颖,曹克刚.中风病二级预防中医药适时干预模式探讨[J].北京中医药大学学报(中医临床版),2010.3,17(2)：24.
[120]蔡业峰.缺血性中风诊断与治疗[M].北京：人民军医出版社,2012.1：210-219.
[121]温长路.科学认识和理解中医的“治未病”说[J].甘肃中医,2008,21(3)：4.
[212]赵盛云.治未病研究现状[J].中华中医药学刊,2010,28(6)：1307.
[123]Larry B. Goldstein, Cheryl D. Bushnell, Robert.J. Adams. Guidelines for the primary prevention of stroke:a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke.2011,42:519-526.
[124]中国国营养学会.中国居民膳食指南[M].拉萨：西藏人民出版社,2010.12：3-103.
[125]王旭东.中医养生康复学[M].北京：中国中医药出版社：,2011.1：208-214.
[126]S Ebrahim, M May, Y Ben Shlomo, P McCarron, S Frankel, J Yarnell, G Davey Smith. Sexual intercourse and risk of ischaemic stroke and coronary heart disease:the Caerphilly study. J Epidemiol Community Health 2002; 56:99-102.
[127]颜德馨,夏翔.中华养生大全[M].上海：上海科学技术出版社,2001.12,：131.
[128]赵水平,胡大一.心血管病诊疗指南解读[M].北京：人民生出版社,2008.10：3.
[129]中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华高血压杂志,2011.08,19(8)：711.
[130]R. McPherson, J. Frohlich, G. Fodor, J. Genest, Canadian Cardiovascular Society position statement-Recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can. J. Cardiology 2006; 22(11):913-927.
[131]中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华高血压杂 志,2011.08,19(8)：709.
[132]中国成人血脂异常防治指南制订联合委员会.中国成人血脂异常防治指南[J].中华心血管病杂志,2007.05,35(5)：395.
[133]张春红,邢瀚,乔波.石学敏治疗高血压病经验[J].中医杂志,2011.10,52(20)：1730.
[134]仝小林.糖尿病中医防治指南解读[M].中国中医药出版社,2009.08：6-7.
[135]中华医学会糖尿病学分会主编.中国2型糖尿病防治指南(2010年版)[M].北京：北京大学医学出版社,2011.5：10.
[136]王旭东.中医养生康复学[M].北京：中国中医药出版社,2011.1：304.
[137]wang XB, Qin XH, Demirtas H, et al. Efficacy of folic acid supplementation in stroke prevention:a Meta analysis. Lancet,2007,369(9576):1876-1882.
[138]靳琦整理.王琦辨体—辨病—辩证诊疗模式[M].北京：中国中医药出版社,2006.4：44-52.
[139]赵水平,胡大一.心血管病诊疗指南解读[M].北京：人民卫生出版社,2008.10：77-78.
[140]中华医学会神经病学分会脑血管病学组缺血性脑卒中二级预防指南撰写组.中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2010[J].中华神经科杂志2010.2,43(2)：155.
[141]中国成人血脂异常防治指南制订联合委员会.中国成人血脂异常防治指南[J].中华心血管病杂志,2007.05,35(5)：400-405.
[142]中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华高血压杂志,2011.08,19(8)：715.
[143]陈鲁原.高血压患者的脑卒中预防(长效CCB与ARB选择之争)[J].心血管网,2011.09：第5版.
[144]中国成人血脂异常防治指南制订联合委员会.中国成人血脂异常防治指南[J].中华心血管病杂志,2007.05,35(5)：401-405.
[145]Ballantyne CM, Blazing MA, King TR, et al. Efficacy and safety of ezetimibe co-administered with simvastatin compared with atovastatin in adults with hypereholesterolemia Am J Cardiol,2004,93 (12);1487-1494.
[146]Ballantyne CM, Houri J, Notarbartolo A, etal Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypereholesterolemia A prospective, randomized, double-blind trial. Circulation,2003,107 (19); 2409-2415.
[147]中华医学会糖尿病学分会主编.中国2型糖尿病防治指南(2010年版)[M].北京：北京大学医学出版社,2011.5：59.
[148]仝小林.糖尿病中医防治指南解读[M].中国中医药出版社,2009.08：351-352.
[149]中华医学会神经病学分会脑血管病学组缺血性脑卒中二级预防指南撰写组.中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2010[J].中华神经科杂志2010.2,43(2)：158.
[150]中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华高血压杂志,2011.08,19(8)：719.
[151]Larry B. Goldstein, Cheryl D. Bushnell, Robert J. Adams. Guidelines for the primary prevention of stroke:a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke.2011,42:556.
[152]中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中华医学信息导报,2010,(14)：16.
[153]中华医学会糖尿病学分会主编.中国2型糖尿病防治指南(2010年版)[M].北京：北京大学医学出版社,2011.5：9-13.
[154]中华医学会糖尿病学分会主编.中国2型糖尿病防治指南(2010年版)[M].北京：北京大学医学出版社,2011.5：15.
[155]Larry B. Goldstein, Cheryl D. Bushnell, Robert J. Adams. Guidelines for the primary prevention of stroke:a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke.2011,42:537.
[156]赵水平,胡大一.心血管病诊疗指南解读[M].北京：人民卫生出版社,2008.10：162.
[157]饶明莉.脑血管病防治指南[M].北京：人民卫生出版社,2007.1：14.
[158]Easton JD, Saver JL, Albers GW, et al.Deftnition and evaluation of transient ischemic attack:a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Counci]:Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke,2009,40:2276-2293.
[159]Albem GW, Caplan LR, Easton JD, et al.'I'ransient ischemic attack-proposal for a new definition. N Engl J Med,2002,347:1713-1716.
[160]短暂性脑缺血发作中国专家共识组.短暂性脑缺血发作的中国专家共识更新版(2011年)[M].中华内科杂志,2011.6,50(6)：536.
[161]中华医学会神经病学分会脑血管病学组缺血性脑卒中二级预防指南撰写组.中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2010[J].中华神经科杂志,2010.2,43(2)：157.
[162]Johnston SC, Roth well PM, Nguyen-Huynh MN, Giles MF, Elkins JS, Bernstein AL, et al. Validation and refinement of scores to predict very early stroke risk after transient ischemic attack. Lancet.2007;369(9558):283-292.
[163]National Stroke Foundation. Clinical Guidelines for Stroke and TIA Management:A guide for general practice. The royal Australian college of general practitioners,2008: 1.
[164]中华医学会神经病学分会脑血管病学组缺血性脑卒中二级预防指南撰写组.中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2010[J].中华神经科杂志,2010.2,43(2)：158.
[165]Berger JS, Roncaglioni MC, Avanzini F, et al. Asprin for the primary prevention of cardiovascular events in women and men:a sex-specific meta-analysis of randomized controlled trials. JAMA,2006,295:306-313.
[166]Ralph L. Sacco, M.D., Hans-Christoph Diener, M. D., Ph.D., Salim Yusuf, M.B., B. S., D. Phi 1, et al. Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke N Engl J Med 2008; 359:1238-1251.
[167]中华医学会神经病学分会脑血管病学组缺血性脑卒中二级预防指南撰写组.中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2010[J].中华神经科杂志,2010.2,43(2)：156-158.
[168]出血性脑血管病诊疗指南[J].中国临床医生,2009,37(8)：73.
[169]Morgenstern LB, Hemphill JC 3rd, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage:a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke.2010;41:00-00.
[170]中华医学会神经病学分会脑血管病学组缺血性脑卒中二级预防指南撰写组.中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2010[J].中华神经科杂志,2010.2,43(2)：155.
[171]Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V. AHA/ACCscientific statement:assessment of cardiovascular risk by use of multiple-risk-factor assessment equations:a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol.1999:34:1348-1359.
[2]王洪图.《黄帝内经》研究大成[M].北京：北京出版社,1997,第1版：1643.
[3](唐)王冰.黄帝内经[M].北京：中医古籍出版社,2003,第1版：1-316.
[4]张锡纯.医学衷中参西录[M].太原：山西科学技术出版社,2009,第1版：320-325.
[5]上海市中医文献研究馆.中风专辑[M].上海：上海科学技术出版社,2001,第1版：81.
[6]王左原.《内经》“治未病”思想的核心—先机扶正[J].中国中医基础医学杂志,2008；14(4)：255-256.
[7]张仲景.中医经典临床必读丛书·匮要略方论[M].北京：中国中医药出版社,2006.10,第1版：19-20
[8]田德禄.中医内科学[M].北京：人民卫生出版社,2002,第1版：272.
[9]陈熠.明清名医全书大成·喻嘉言医学全书[M].北京：中国中医药出版社,1999,第1版：243-244.
[10]叶天士中医临床必读丛书·临证指南医案[M].北京：人民卫生出版社,2006,第1版：19
[11]李敬孝,张岩.侯氏黑散对ICVD兔血流变及脂质过氧化物影响的实验研究[J].四川中医,2007：25(1)：20.
[12]张秋霞,赵晖.侯氏黑散对大鼠大脑中动脉闭塞模型缺血脑组织Na+K+ATP酶及一氧化氮合酶活性的影响[J].首中国实验方剂学杂志,2008；14(7)：31
[13]谭春雨.中医经典临床必读丛书·中藏经[M].北京：人民卫生出版社,2007,第1版：38-45.
[14]丁光迪,倪和宪,王旭东等.诸病源侯论校注[M].北京：人民卫生出版社,1991,第1版：1-55.
[15]张印生,韩学杰.孙思邈医学全书[M].北京：中国中医药出版社,2009,第1版：83-479.
[16]严天放.孙思邈的养生之道[J].养生月刊,2010；1(1)：006
[17]富作平,裴景春.古代中风病针灸处方配穴原则及规律的探讨[J].辽宁中医杂志,2002；29(6)：320
[18]周敬佐.灸治中风60例.辽宁中医杂志,1994；21(11)：521.
[19](唐)王焘.外台秘要[M].北京：人民卫生出版社,1955,第1版：397-398.
[20]姜琳祛风通络说桑枝[J].东方药膳,2009;(03)：38
[21]国家医药管理局中草药中心情报站.药物有效成分手册[M].北京：人民卫生出版社,1986,第1版：123-130.
[22]刘完素.金元四大家医学全书—上册(刘完素医学文集)[M].天津：天津科学技术出版社,1996,第1版：11-164.
[23]丁元庆.论刘完素对中风病的贡献[J].中医文献杂志,1998；16(3)：5-6.
[24]朱震亨.金元四大家医学全书—下册(朱震亨医学文集)[M].天津：天津科学技术出版社,1996,第1版：1685.
[25]盛维忠《薛立斋医学全书·内科摘要》[M].北京：中国中医药出版社,1999,第1版：5.
[26]许沛虎涂晋文.愈风汤对大鼠脑缺血再灌流损伤的保护作用[J].中国中医急症,1997;6(4)：176.
[27]许沛虎涂晋文.愈风汤对大鼠实验性高脂血症血脂及血液流变性的影响[J].湖北中医杂志,1996; (5)：53.
[28]许沛虎涂晋文.愈风汤对大鼠短暂脑缺血再灌注后迟发性神经元死亡加重的保护作用[J].中国实验方剂学杂志,2001;7(5)：30.
[29]李东垣.金元四大家医学全书—上册(李杲医学文集)[M].天津：天津科学技术出版社,1996,第1版：756.
[30]谭春雨.中医经典临床必读丛书·中藏经[M].北京：人民卫生出版社,2007,第1版：63.
[31]朱震亨.金元四大家医学全书—下册(朱震亨医学文集)[M].天津：天津科学技术出版社,1996,第1版：983.1059-1060,1125-1129,1256-1257,1343-1344,1422-1428,1685-1686.
[32]王执中著,黄龙强,黄幼民整理.《针灸资生经／针经摘英集》[M].北京：人民卫生出版社,2007,第1版：182-189.
[33](元)罗天益.卫生宝鉴[M].北京：人民卫生出版社,1983,第1版：4,3,56-75,87.
[34]王和融.薛己论中风病因探要[J].中国中医急症,2003；12(4)：355.
[35]盛维忠.明清名医全书大成·薛己医学全书[M].中国中医药出版社.1999,第1版：5,20.
[36]李志庸.明清名医全书大成·张景岳医学全书[M].北京：中国中医药出版社,1999,第1版：984-1001.
[37]李志庸.明清名医全书大成·张景岳医学全书[M].北京：中国中医药出版社,1999,第1版：899.
[38]赵献可.中医临床必读丛书·医贯[M].北京：人民卫生出版社,2005,第1版：21-31.
[39]包来发.李中梓医学全书[M].北京：中国中医药出版社,1999,第1版：181-190.
[40]包来发.李中梓医学全书[M].北京：中国中医药出版社,1999,第1版：655-656.
[41]李世华,王育学.龚廷贤医学全书[M].北京：中国中医药出版社,1999,第1版：3-5,253-786.
[42]唐东一.搜风顺气丸治疗代谢综合征120例[J].山东中医杂志,2007;26(3)：163.
[43]苏建春.补中益气汤洽验举隅[J].新疆中医药,1995；(1)：49.
[44]李世华,王育学.龚廷贤医学全书[M].北京：中国中医药出版社,1999,第1版：607.
[45]陈熠.喻嘉言医学全书·医门法律[M].北京：中国中医药出版社,1999.8：238
[46]清·喻嘉言.中医经典文库·寓意草[M].北京：中国中医药出版社,2008.12：98
[47]陈熠.喻嘉言医学全书·医门法律[M].北京：中国中医药出版社,1999.8：246-255.
[48]清·姜天叙.风劳朦隔四大证治[M].江苏人民出版社,1957：6-7.
[49]李用粹.中医临床必读丛书·证治汇补[M].北京：人民卫生出版社,2006.6：1.
[50]S Ebrahim, M May, Y Ben Shlomo, P McCarron. J Epidemiol Community Health [J] 2002, 56:102.
[51]田思胜.明清名医全书大成·沈金鳌医学全书[M].北京：中国中医药出版社,1999：221-234.
[52]林惠光,俞宜年.陈修园医学全书·医学实在易[M].北京：中国中医药出版社,1999.8：561-562
[53]孙中堂.尤在泾医学全书·金匮翼[M].北京：中国中医药出版社,1999.8：189-193
[54]林惠光,俞宜年.陈修园医学全书·时方妙用[M].北京：中国中医药出版社,1999.8：881-882.
[55]清·叶天士.临证指南医案[M].上海：人民卫生出版社,2006.6：19.
[56]明国臣.叶天士医学全书[M].北京：中国中医药出版社,1999.1041.
[57]谢文英,常学辉.中国中医基础医学杂志[J].2007,13(5)：330.
[58]清·叶天士.临证指南医案[M].上海：人民卫生出版社,2006.6：6-10.
[59]清·王清任.医林改错[M].太原：陕西科学技术出版社,2010.7：84-102.
[60]Liao CL, Tong L, Chen YY. Effect of Buyanghuanwu decoction on neuronal nitric-oxide synthase ex-pression after permanent focal cerebral ischemia in rats. Di Yi Jun Yi Da Xue Xue Bao,2004,24 (8):864-868
[61]Qu HD, Tong L, Shen J G, etal. Protective effect of Buyanghuanwu Tang on cultured rat cortical neurons against hypoxia induced apoptosis. Di Yi Jun Yi Da Xue Xue Bao,2002, 22 (1):35-38
[62]Zhang J, Li C, Guo X, et al. Effect of buyang huanwu decoction on platelet activating factor content in arterial blood pre-and post-arterial thrombosis in rats. Journal of Traditional Chinese Medicine,2001,21 (4):299-302.
[63]Liu FY, Wen ZB, Zhou CS, et al. "Buyang huanwutang" inhibited the pathogenic process of atherosclerosis induced by cholesterol-rich diet in rabbits. Hu Nan Yi Ke Da Xue Xue Bao,2000,25(1):33-35.
[64]张习东.补阳还五汤防治进展型中风病36例[J].云南中医中药杂志,2009,30(8)：27.
[65]吴云虎,黄龙坚,王殿华.气虚血瘀型再狭窄预防作用研究[J].新中医,2011.5,43(5)：19.
[66]方东海,李明淑,付杰等.补阳还五汤预防脑梗塞复发率及其生存率的对照观察[J].中医药学刊,2004.6,22(6)：1107.
[67]王华.补阳逐五汤治疗气虚血瘫型中风先兆26例[J].中国中医急症,1999.12,8(6)：280.
[68]闫润红 王世民 闫志芳不同黄芪剂量的补阳还五汤对“气虚血瘀”家兔血粘度的影响[J].中药药理与临床,1999,15(1)：7.
[69]张运克.补阳还五汤及拆方抗脑缺血.及再灌注损伤作用机理的临床与实验研究[D].黑龙江中医药大学2002.5：2.
[70]张十骧著,裘庆元辑.历代图书珍本集成-国医百家-类中秘旨[M].工医药学报 社,1917：1-12.
[71]张士骧著,裘庆元辑.历代图书珍本集成-国医百家-雪雅堂医案[M].医学全在线：395,397,403.
[72]于诗俊,叶德铭,盛增秀等.张山雷医集下[M].北京：人民卫生出版社,1995：61.
[73]于诗俊,叶德铭,盛增秀等.张山雷医集下[M].北京：人民卫生出版社,1995：90.
[74]张锡纯.医学衷中参西录[M].太原：山西科学技术出版社,2009.1：155-158,164-167,320-325,351-356,476-481.
[75]蔡业峰.缺血性中风诊断与治疗[M].北京：人民军医出版社,2012.1：204.
[76]任继学.任继学经验集[M].北京：人民卫生出版社,2000：97-112.
[77]任继学.任继学经验集[M].北京：人民卫生出版社,2000：127-138.
[78]张学文,李军等.近代中医名家论治中风病荟萃[M].西安：陕西科学技术出版社,1997.8：190-193.
[79]王景洪,李军,张宏伟.张学文医学求索集[M]..西安：陕西科学技术出版社,1996.01：284-288.
[80]任继学.任继学经验集[M].北京：人民卫生出版社,2000：115.
[81]上海市中风预报协作组.缺血性中风先兆预报和预防性治疗的初步探讨[J].中华医学杂志,1979：12：1-3.
[82]金智敏.珍菊降压片与其他一线降压药治疗原发性高血压临床研究[J].中成药,2001,23(12)：882-884.
[83]申鹏飞.针刺治疗亚急性原发性高血.压病30例.中医杂志,2010,51(1)：57-58.
[84]申鹏飞,石学敏.针刺治疗原发性高血.压病的临床疗效观察.辽宁中医杂志,2010,37(9)：1802-1803.
[85]王宁,张昆,郑君.隔芪香散灸脐法治疗高血压肝阳上亢证30例[J].四川中医,2007,25(4)：6.
[86]吴晓青,杨婷.高血压病的中医研究进展.北京中医药大学学报(中医临床版)[J]2010.07,17(4)：39.
[87]仝小林.糖尿病中医防治指南解读[M].中国中医药出版社,2009.08：14-15.
[88]冯新玲,张定华.糖尿病前期中医证治研究进展[J].实用中医药杂志2011.10,27(10)：736.
[89]仝小林,赵昱,陈良.胰岛B细胞功能保护的中医认识与对策[J].中医杂志,2006,47(12)888-890.
[90]周水平,罗若兰.疏肝健脾法对葡萄糖耐量减低干预作用的临床研究[J].中西医结合研究,2010,6(2)：284-287.
[91]仝小林.糖尿病中医防治指南解读—中医治疗糖尿病的研究进展[M].中国中医药出版社,2009.08：271
[92]谷浩荣,贾春华.糖尿病中医病机及治法研究进展[J].上海中医药杂志,2011,45(1)：84.
[93]陈婷,吴伟,李荣等.血脂异常中医病因病机及治法研究进展[J].北京中医药大学学报(中医临床版),2008.01,15(1)：39-40.
[94]潘涛,施广飞.血脂异常的中医研究进展[J].中西医结合心脑血.管病杂志,2008,6(1)：51-52.
[95]徐玉华,朱雅萍.中医治未病思想防治高脂血症研究进展[J]. 陕西中医2011,32(4)：500-501.
[96]赵水平.血脂异常临床防治2011-2012[M].中华医学电子音像出版社,2011.06：144-145.
[97]吴圣贤,方素钦,林炳辉.脑动脉硬化症的计量诊断研究[J].北京中医药大学学报,2006,29(8)：569.
[98]吴圣贤,林炳辉,方素钦.脑动脉硬化症中医计量诊断前瞻性研究[J].中医杂志,2006,47(7)：535.
[99]Zhang HX, Liu JG, Shi DZ. Effects o f Qixue Bingzhi prescription on hypersensitive C-reactive protein and other indexes in the patient o f cervical atherosclerosis. J Tradit Chin Med(中医杂志),2004,45(12)：907-910.
[100]Dong GJ, Liu JG, Shi DZ, Wang YY, Luan LJ, Cheng YY. Experimental study of water extractives of regulating Qi and Xue prescription on early AS of apo-lipoprotein E deficient mice. J Chin Integrat Med(中西医结合学报),2007,1(5)：45-49.
[101]Ji B, Liu JG, Shi DZ, Wang YY. Effects of different combinations of the active fractions of Qixuebingzhi Formula on VSM C proliferation induced by vascular endothelial cell injury-conditioned medium. J Beijing Univ Tradit Chin Med(北京中医药大学学报),2005,28(1)：30-32.
[102]董国菊,刘剑刚,史大卓.气血并治方胶囊治疗颈动脉粥样硬化的临床研究[J].世界中西医结合杂志,2008,3(1)：29.
[103]田德禄中医内科学[M].北京：人民卫生出版社,2002：271.
[104]王忠,张伯礼,申春娣,等.中风病中医危险因素研究[J].北京中医药大学学报,2002,25(5)：47：52.
[105]许越.中医体质学说在中风病一级预防中的理论研究[D].广州,广州中医药大学,2008：77-78.
[106]王琦.中医体质学[M].北京：人民卫生出版社,2005,第一版：79-82.
[107]王泓午,王玉来,王振海等.缺血性中风发病前24小时内先兆期症状的病例对照研究[J].北京中医药大学学报,1998,21(4)：2.
[108]王泓午,王玉来,金章安等.缺血性中风发病前24-72小时内症状的条件logistic回归分析[J].中国中医急症,2002,11(5)：370.
[109]王泓午,王玉来,金章安等.缺血性中风发病前3-7天内症状的条件logistic回归分析[J].中国中医急症,2003,12(1)：40.
[110]王泓午,王玉来,金章安等.缺血性中风发病前7-30 d内症状的病例对照研究[J].天津中医药,2004,11(6)：470.
[111]张鹤年.缺血性中风的先兆检测与防治[J].上海中医药杂志,1990,5：26.
[112]陈宝生.葛根素治疗中风先兆证临床观察[J].中国中医急症,2004,13(9)：563-564.
[113]杨保林.清开灵治疗中风先兆证56例[J].中国中医急症,1998,7(1)：20.
[114]王舒,石学敏,张存生.“醒脑开窍”针刺法治疗中风先兆的血液流变学观察[J].针灸临床杂志,1995,11(6)：25-28.
[115]徐桂琴,谢雁鸣,邹忆怀等.缺血性中风避免复发中医研究现状[J].辽宁中医杂志,2009,36(5)：858.
[116]邓小兰,赵红,黄燕等.中风病二级预防的研究进展[J].陕西中医,2009,30(9)：1268.
[117]黄燕,陈绍宏.中药灯盏生脉胶囊干预缺血性中风二级预防的多中心、随机对照、双盲临床试验[J].解放军医学杂志,2011.11,36珠江国际卒中论坛会议增刊：3.
[118]常富业,郭玉荣,李辉等.中医学关于卒中二级预防的研究状况与述评[J].辽宁中医杂志,2007,34(5)：567.
[119]陈颖,曹克刚.中风病二级预防中医药适时干预模式探讨[J].北京中医药大学学报(中医临床版),2010.3,17(2)：24.
[120]蔡业峰.缺血性中风诊断与治疗[M].北京：人民军医出版社,2012.1：210-219.
[121]温长路.科学认识和理解中医的“治未病”说[J].甘肃中医,2008,21(3)：4.
[212]赵盛云.治未病研究现状[J].中华中医药学刊,2010,28(6)：1307.
[123]Larry B. Goldstein, Cheryl D. Bushnell, Robert.J. Adams. Guidelines for the primary prevention of stroke:a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke.2011,42:519-526.
[124]中国国营养学会.中国居民膳食指南[M].拉萨：西藏人民出版社,2010.12：3-103.
[125]王旭东.中医养生康复学[M].北京：中国中医药出版社：,2011.1：208-214.
[126]S Ebrahim, M May, Y Ben Shlomo, P McCarron, S Frankel, J Yarnell, G Davey Smith. Sexual intercourse and risk of ischaemic stroke and coronary heart disease:the Caerphilly study. J Epidemiol Community Health 2002; 56:99-102.
[127]颜德馨,夏翔.中华养生大全[M].上海：上海科学技术出版社,2001.12,：131.
[128]赵水平,胡大一.心血管病诊疗指南解读[M].北京：人民生出版社,2008.10：3.
[129]中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华高血压杂志,2011.08,19(8)：711.
[130]R. McPherson, J. Frohlich, G. Fodor, J. Genest, Canadian Cardiovascular Society position statement-Recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can. J. Cardiology 2006; 22(11):913-927.
[131]中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华高血压杂 志,2011.08,19(8)：709.
[132]中国成人血脂异常防治指南制订联合委员会.中国成人血脂异常防治指南[J].中华心血管病杂志,2007.05,35(5)：395.
[133]张春红,邢瀚,乔波.石学敏治疗高血压病经验[J].中医杂志,2011.10,52(20)：1730.
[134]仝小林.糖尿病中医防治指南解读[M].中国中医药出版社,2009.08：6-7.
[135]中华医学会糖尿病学分会主编.中国2型糖尿病防治指南(2010年版)[M].北京：北京大学医学出版社,2011.5：10.
[136]王旭东.中医养生康复学[M].北京：中国中医药出版社,2011.1：304.
[137]wang XB, Qin XH, Demirtas H, et al. Efficacy of folic acid supplementation in stroke prevention:a Meta analysis. Lancet,2007,369(9576):1876-1882.
[138]靳琦整理.王琦辨体—辨病—辩证诊疗模式[M].北京：中国中医药出版社,2006.4：44-52.
[139]赵水平,胡大一.心血管病诊疗指南解读[M].北京：人民卫生出版社,2008.10：77-78.
[140]中华医学会神经病学分会脑血管病学组缺血性脑卒中二级预防指南撰写组.中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2010[J].中华神经科杂志2010.2,43(2)：155.
[141]中国成人血脂异常防治指南制订联合委员会.中国成人血脂异常防治指南[J].中华心血管病杂志,2007.05,35(5)：400-405.
[142]中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华高血压杂志,2011.08,19(8)：715.
[143]陈鲁原.高血压患者的脑卒中预防(长效CCB与ARB选择之争)[J].心血管网,2011.09：第5版.
[144]中国成人血脂异常防治指南制订联合委员会.中国成人血脂异常防治指南[J].中华心血管病杂志,2007.05,35(5)：401-405.
[145]Ballantyne CM, Blazing MA, King TR, et al. Efficacy and safety of ezetimibe co-administered with simvastatin compared with atovastatin in adults with hypereholesterolemia Am J Cardiol,2004,93 (12);1487-1494.
[146]Ballantyne CM, Houri J, Notarbartolo A, etal Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypereholesterolemia A prospective, randomized, double-blind trial. Circulation,2003,107 (19); 2409-2415.
[147]中华医学会糖尿病学分会主编.中国2型糖尿病防治指南(2010年版)[M].北京：北京大学医学出版社,2011.5：59.
[148]仝小林.糖尿病中医防治指南解读[M].中国中医药出版社,2009.08：351-352.
[149]中华医学会神经病学分会脑血管病学组缺血性脑卒中二级预防指南撰写组.中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2010[J].中华神经科杂志2010.2,43(2)：158.
[150]中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华高血压杂志,2011.08,19(8)：719.
[151]Larry B. Goldstein, Cheryl D. Bushnell, Robert J. Adams. Guidelines for the primary prevention of stroke:a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke.2011,42:556.
[152]中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中华医学信息导报,2010,(14)：16.
[153]中华医学会糖尿病学分会主编.中国2型糖尿病防治指南(2010年版)[M].北京：北京大学医学出版社,2011.5：9-13.
[154]中华医学会糖尿病学分会主编.中国2型糖尿病防治指南(2010年版)[M].北京：北京大学医学出版社,2011.5：15.
[155]Larry B. Goldstein, Cheryl D. Bushnell, Robert J. Adams. Guidelines for the primary prevention of stroke:a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke.2011,42:537.
[156]赵水平,胡大一.心血管病诊疗指南解读[M].北京：人民卫生出版社,2008.10：162.
[157]饶明莉.脑血管病防治指南[M].北京：人民卫生出版社,2007.1：14.
[158]Easton JD, Saver JL, Albers GW, et al.Deftnition and evaluation of transient ischemic attack:a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Counci]:Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke,2009,40:2276-2293.
[159]Albem GW, Caplan LR, Easton JD, et al.'I'ransient ischemic attack-proposal for a new definition. N Engl J Med,2002,347:1713-1716.
[160]短暂性脑缺血发作中国专家共识组.短暂性脑缺血发作的中国专家共识更新版(2011年)[M].中华内科杂志,2011.6,50(6)：536.
[161]中华医学会神经病学分会脑血管病学组缺血性脑卒中二级预防指南撰写组.中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2010[J].中华神经科杂志,2010.2,43(2)：157.
[162]Johnston SC, Roth well PM, Nguyen-Huynh MN, Giles MF, Elkins JS, Bernstein AL, et al. Validation and refinement of scores to predict very early stroke risk after transient ischemic attack. Lancet.2007;369(9558):283-292.
[163]National Stroke Foundation. Clinical Guidelines for Stroke and TIA Management:A guide for general practice. The royal Australian college of general practitioners,2008: 1.
[164]中华医学会神经病学分会脑血管病学组缺血性脑卒中二级预防指南撰写组.中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2010[J].中华神经科杂志,2010.2,43(2)：158.
[165]Berger JS, Roncaglioni MC, Avanzini F, et al. Asprin for the primary prevention of cardiovascular events in women and men:a sex-specific meta-analysis of randomized controlled trials. JAMA,2006,295:306-313.
[166]Ralph L. Sacco, M.D., Hans-Christoph Diener, M. D., Ph.D., Salim Yusuf, M.B., B. S., D. Phi 1, et al. Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke N Engl J Med 2008; 359:1238-1251.
[167]中华医学会神经病学分会脑血管病学组缺血性脑卒中二级预防指南撰写组.中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2010[J].中华神经科杂志,2010.2,43(2)：156-158.
[168]出血性脑血管病诊疗指南[J].中国临床医生,2009,37(8)：73.
[169]Morgenstern LB, Hemphill JC 3rd, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage:a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke.2010;41:00-00.
[170]中华医学会神经病学分会脑血管病学组缺血性脑卒中二级预防指南撰写组.中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2010[J].中华神经科杂志,2010.2,43(2)：155.
[171]Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V. AHA/ACCscientific statement:assessment of cardiovascular risk by use of multiple-risk-factor assessment equations:a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol.1999:34:1348-1359.